3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
24
Observational
2
Sponsor
Cancer Type
Gastrointestinal
22
Genitourinary
17
Other hematologic neoplasm
4
Head & Neck
2
Thoracic
1
NET
1
Myeloid
1
Endocrine
1
Conditions
Thyroid Neoplasms
2
Interventions
Surveys and Questionnaires
40
Blood Specimen Collection
30
Radiotherapy
20
Immunohistochemistry
13
Gene Expression Profiling
12
Radiotherapy, Intensity-Modulated
11
Cisplatin
11
Surgical Procedures, Operative
10
Biopsy
10
Drug Therapy
9
Cetuximab
9
Ultrasonography
8
Thyroidectomy
8
Observation
8
Transurethral Resection of Prostate
7
Nivolumab
7
Interviews as Topic
7
pembrolizumab
6
Therapeutics
6
Radiation
6
Polymerase Chain Reaction
6
Immunotherapy
6
Biopsy, Fine-Needle
6
Positron Emission Tomography Computed Tomography
5
Microarray Analysis
5
Liquid Biopsy
5
Iodine-131
5
Docetaxel
5
Chemoradiotherapy
5
Tissue Banks
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Sorafenib
×
Head & Neck
×
Clear all
NCT02185560
2026-04-14
JPMS-DTC
Bayer
Active not recruiting
453 enrolled
NCT02303444
2023-06-08
RIFTOS MKI
Bayer
Completed
667 enrolled